Cargando…

Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries

BACKGROUND AND AIM: Serum Golgi protein 73 (GP73) is a promising alternative biomarker of chronic liver diseases, but most data are from patients with HBV infection rather than HCV. MATERIALS AND METHODS: Two independent cohorts of chronic hepatitis C (CHC) patients from the 5th Medical Centre of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Xiangjun, Zheng, Sujun, Wang, Leijie, Yao, Mingjie, Guan, Guiwen, Wen, Xiajie, Zhang, Ling, Xu, Qiang, Chen, Xiangmei, Zhao, Jingmin, Duan, Zhongping, Lu, Fengmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766121/
https://www.ncbi.nlm.nih.gov/pubmed/31636735
http://dx.doi.org/10.1155/2019/3862024
_version_ 1783454646216425472
author Qian, Xiangjun
Zheng, Sujun
Wang, Leijie
Yao, Mingjie
Guan, Guiwen
Wen, Xiajie
Zhang, Ling
Xu, Qiang
Chen, Xiangmei
Zhao, Jingmin
Duan, Zhongping
Lu, Fengmin
author_facet Qian, Xiangjun
Zheng, Sujun
Wang, Leijie
Yao, Mingjie
Guan, Guiwen
Wen, Xiajie
Zhang, Ling
Xu, Qiang
Chen, Xiangmei
Zhao, Jingmin
Duan, Zhongping
Lu, Fengmin
author_sort Qian, Xiangjun
collection PubMed
description BACKGROUND AND AIM: Serum Golgi protein 73 (GP73) is a promising alternative biomarker of chronic liver diseases, but most data are from patients with HBV infection rather than HCV. MATERIALS AND METHODS: Two independent cohorts of chronic hepatitis C (CHC) patients from the 5th Medical Centre of the Chinese PLA General Hospital (n = 174) and Beijing Youan Hospital (n = 120) with different histories of HCV infection were enrolled. The correlations between serum GP73 and other biochemical indices, as well as its correlations with different stages of liver disease progression, were investigated. The receiver operating characteristic (ROC) curve was employed to evaluate the diagnostic potential of serum GP73 for liver necroinflammation and fibrosis, and comparisons of the diagnostic efficiency with traditional indices of hepatic liver injuries were further investigated. RESULTS: Levels of serum GP73 were found significantly elevated in patients with moderate to severe inflammatory grade (G ≥ 2) and/or with advanced fibrotic stages (F ≥ 3) in both cohorts (P < 0.05, respectively), as compared to those with a normal or mild liver lesion. Further ROC analysis demonstrated that serum GP73 was comparable to serum ALT and AST in diagnosing the liver necroinflammation grade at G ≥ 2, but its diagnostic values for advanced fibrosis (F ≥ 3) and cirrhosis (F = 4) were limited when compared to APRI and FIB-4, and FIB-4 exhibited the best performance. Notably, an obvious elevation of serum GP73 was observed after patients received PEG-IFN and ribavirin treatment. CONCLUSIONS: Serum GP73 is an important biomarker in evaluating and monitoring the disease progression including liver necroinflammation and fibrosis in patients with chronic HCV infection, but the value is limited for diagnosing advanced fibrosis and cirrhosis in comparison with APRI and FIB-4.
format Online
Article
Text
id pubmed-6766121
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-67661212019-10-21 Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries Qian, Xiangjun Zheng, Sujun Wang, Leijie Yao, Mingjie Guan, Guiwen Wen, Xiajie Zhang, Ling Xu, Qiang Chen, Xiangmei Zhao, Jingmin Duan, Zhongping Lu, Fengmin Dis Markers Research Article BACKGROUND AND AIM: Serum Golgi protein 73 (GP73) is a promising alternative biomarker of chronic liver diseases, but most data are from patients with HBV infection rather than HCV. MATERIALS AND METHODS: Two independent cohorts of chronic hepatitis C (CHC) patients from the 5th Medical Centre of the Chinese PLA General Hospital (n = 174) and Beijing Youan Hospital (n = 120) with different histories of HCV infection were enrolled. The correlations between serum GP73 and other biochemical indices, as well as its correlations with different stages of liver disease progression, were investigated. The receiver operating characteristic (ROC) curve was employed to evaluate the diagnostic potential of serum GP73 for liver necroinflammation and fibrosis, and comparisons of the diagnostic efficiency with traditional indices of hepatic liver injuries were further investigated. RESULTS: Levels of serum GP73 were found significantly elevated in patients with moderate to severe inflammatory grade (G ≥ 2) and/or with advanced fibrotic stages (F ≥ 3) in both cohorts (P < 0.05, respectively), as compared to those with a normal or mild liver lesion. Further ROC analysis demonstrated that serum GP73 was comparable to serum ALT and AST in diagnosing the liver necroinflammation grade at G ≥ 2, but its diagnostic values for advanced fibrosis (F ≥ 3) and cirrhosis (F = 4) were limited when compared to APRI and FIB-4, and FIB-4 exhibited the best performance. Notably, an obvious elevation of serum GP73 was observed after patients received PEG-IFN and ribavirin treatment. CONCLUSIONS: Serum GP73 is an important biomarker in evaluating and monitoring the disease progression including liver necroinflammation and fibrosis in patients with chronic HCV infection, but the value is limited for diagnosing advanced fibrosis and cirrhosis in comparison with APRI and FIB-4. Hindawi 2019-09-17 /pmc/articles/PMC6766121/ /pubmed/31636735 http://dx.doi.org/10.1155/2019/3862024 Text en Copyright © 2019 Xiangjun Qian et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Qian, Xiangjun
Zheng, Sujun
Wang, Leijie
Yao, Mingjie
Guan, Guiwen
Wen, Xiajie
Zhang, Ling
Xu, Qiang
Chen, Xiangmei
Zhao, Jingmin
Duan, Zhongping
Lu, Fengmin
Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries
title Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries
title_full Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries
title_fullStr Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries
title_full_unstemmed Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries
title_short Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries
title_sort exploring the diagnostic potential of serum golgi protein 73 for hepatic necroinflammation and fibrosis in chronic hcv infection with different stages of liver injuries
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766121/
https://www.ncbi.nlm.nih.gov/pubmed/31636735
http://dx.doi.org/10.1155/2019/3862024
work_keys_str_mv AT qianxiangjun exploringthediagnosticpotentialofserumgolgiprotein73forhepaticnecroinflammationandfibrosisinchronichcvinfectionwithdifferentstagesofliverinjuries
AT zhengsujun exploringthediagnosticpotentialofserumgolgiprotein73forhepaticnecroinflammationandfibrosisinchronichcvinfectionwithdifferentstagesofliverinjuries
AT wangleijie exploringthediagnosticpotentialofserumgolgiprotein73forhepaticnecroinflammationandfibrosisinchronichcvinfectionwithdifferentstagesofliverinjuries
AT yaomingjie exploringthediagnosticpotentialofserumgolgiprotein73forhepaticnecroinflammationandfibrosisinchronichcvinfectionwithdifferentstagesofliverinjuries
AT guanguiwen exploringthediagnosticpotentialofserumgolgiprotein73forhepaticnecroinflammationandfibrosisinchronichcvinfectionwithdifferentstagesofliverinjuries
AT wenxiajie exploringthediagnosticpotentialofserumgolgiprotein73forhepaticnecroinflammationandfibrosisinchronichcvinfectionwithdifferentstagesofliverinjuries
AT zhangling exploringthediagnosticpotentialofserumgolgiprotein73forhepaticnecroinflammationandfibrosisinchronichcvinfectionwithdifferentstagesofliverinjuries
AT xuqiang exploringthediagnosticpotentialofserumgolgiprotein73forhepaticnecroinflammationandfibrosisinchronichcvinfectionwithdifferentstagesofliverinjuries
AT chenxiangmei exploringthediagnosticpotentialofserumgolgiprotein73forhepaticnecroinflammationandfibrosisinchronichcvinfectionwithdifferentstagesofliverinjuries
AT zhaojingmin exploringthediagnosticpotentialofserumgolgiprotein73forhepaticnecroinflammationandfibrosisinchronichcvinfectionwithdifferentstagesofliverinjuries
AT duanzhongping exploringthediagnosticpotentialofserumgolgiprotein73forhepaticnecroinflammationandfibrosisinchronichcvinfectionwithdifferentstagesofliverinjuries
AT lufengmin exploringthediagnosticpotentialofserumgolgiprotein73forhepaticnecroinflammationandfibrosisinchronichcvinfectionwithdifferentstagesofliverinjuries